European Archives - Page 613 of 1123 - European Medical Journal

Interview: Prof Ilona Kickbusch

In your impressive, nearly four-decade career in global health, particularly with the World Health Organization (WHO), how have strategies…

Nutritional Management of Patients with Chronic Kidney Disease Through Low-Protein Diets

Chronic kidney disease (CKD) is a global health problem, affecting approximately 10% of the adult population. It has a significant impact on patient…

Optimising Response to Advanced Therapies in Rheumatoid Arthritis - Using Prehabilitation to Improve Success?

This article explores applying the principle of prehabilitation to patients with rheumatoid arthritis prior to starting advanced therapies, including…

Clinical Profile and Outcome of Children with Acute Central Nervous System Infection in Kerala, India

Infection of the central nervous system is a significant cause of morbidity and mortality in children.

Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis

To evaluate changes in microbial composition and the evolution of gastrointestinal tract (GIT) symptoms in systemic sclerosis (SSc).

EMJ 5.4 2020

EMJ 5.4 includes the latest interviews, research articles, and features across disciplines including microbiology and infectious diseases, rheumatology, and urology.

EMJ Neurology 8 [Supplement 2] 2020 Feature Image

The Role of Sphingosine 1-Phosphate Receptor Modulators in the Treatment of Multiple Sclerosis

Neurologists are familiar with S1P receptor modulators as a class, largely based on several years’ experience with fingolimod. Siponimod and ozanimod…

EMJ Neurology 8 [Supplement 2] 2020 Feature Image

EMJ Neurology 8 [Supplement 2] 2020

In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored…

Editor's Pick: Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage

Cytokines are essential regulators of the immune response that mediate protective inflammation, but uncontrolled production by hyperactivated immune cells induces toxicity and adverse conditions…

Talking to Isma Benattia

Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.